The immunology of COVID-19: is immune modulation an option for treatment?

In December, 2019, an outbreak of COVID-19 emerged in Wuhan, China and quickly spread
globally. As of May 7, 2020, there were 3 672 238 confirmed infections and 254 045
deaths attributed to COVID-19. Evidence has shown that there are asymptomatic carriers
of COVID-19 who can transmit the disease to others. The virus incubation time shows
a wide range (0–24 days) and the virus displays a high infectivity. It is therefore
urgent to develop an effective therapy to treat patients with COVID-19 and to control
the spread of the causative agent, severe respiratory syndrome coronavirus 2.

Sourced through from: